Understanding OUR Cytokine-Based Immunotherapy Candidates Our Commitment extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment options remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline We're https://financefeeds.com/klarna-eyes-nyse-debut-with-15b-valuation-fintechs-watch-closely/